Previous Close | 1.7300 |
Open | 1.7200 |
Bid | 1.8200 x 300 |
Ask | 1.8900 x 300 |
Day's Range | 1.7100 - 1.9150 |
52 Week Range | 1.6700 - 11.4800 |
Volume | |
Avg. Volume | 1,140,118 |
Market Cap | 130.815M |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.3500 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.50 |
Key Insights Significantly high institutional ownership implies Ventyx Biosciences' stock price is sensitive to their...
Ventyx Biosciences, Inc. ( (VTYX) ) has released its Q3 earnings. Here is a breakdown of the information Ventyx Biosciences, Inc. presented to its investors. Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focusing on the development of novel oral therapies for autoimmune and inflammatory disorders, aiming to transition treatments from injectable to oral formats. In its latest earnings report for the third quarter of 2024, Ventyx Biosciences